Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer

Br J Surg. 2010 Aug;97(8):1269-78. doi: 10.1002/bjs.7107.

Abstract

Background: This study investigated the association of mucins and cluster of differentiation (CD) 56 with vascular and perineural invasion and survival in patients with periampullary cancer.

Methods: Immunohistochemical staining was performed on formalin-fixed pancreatic tissue microarrays (cancer, chronic pancreatitis and normal pancreatic tissue) constructed from 126 pancreatic resections (cancer, 104; chronic pancreatitis, 22). Mucin (MUC) 1, MUC4 and MUC5AC expression was quantified using the immunohistochemical score (range 0-300), MUC3 expression was described as membranous or cytoplasmic, and expression of CD56, MUC2 and MUC6 as present or absent.

Results: In cancers, vascular invasion correlated with overexpression (immunohistochemical score of 100 or more) of MUC1 (P = 0.003) and presence of MUC6 (P = 0.024), and perineural invasion correlated with overexpression of MUC5AC (P = 0.015). Reduced survival was observed with overexpression of MUC4 (P = 0.032) and MUC5AC (P = 0.048), membranous expression of MUC3 (P = 0.048), and presence of CD56 (P = 0.041). Perineural invasion also correlated with CD56 expression (P = 0.001). Overexpression of MUC4 and MUC5AC correlated with tumour recurrence (P = 0.001 and P = 0.034 respectively). Multivariable analysis identified membranous expression of MUC3 (P = 0.023), lymphatic invasion (P = 0.015) and perineural invasion (P = 0.004) as independent predictors of poor survival.

Conclusion: Mucins and CD56 may be markers of prognosis in patients with periampullary cancer.

MeSH terms

  • Aged
  • Ampulla of Vater* / pathology
  • Biomarkers, Tumor / metabolism*
  • CD56 Antigen / metabolism*
  • Common Bile Duct Neoplasms / diagnosis*
  • Common Bile Duct Neoplasms / mortality
  • Common Bile Duct Neoplasms / pathology
  • Female
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Mucins / metabolism*
  • Neoplasm Invasiveness
  • Pancreatitis, Chronic / diagnosis
  • Prognosis

Substances

  • Biomarkers, Tumor
  • CD56 Antigen
  • Mucins